慢性阻塞性肺部疾病的老年人肺部康复利用,2013-2019年
Surya P Bhatt1, Jordan Westra2, Yong-Fang Kuo2
1Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama; and.
Annals of the American Thoracic Society
|January 19, 2024
概括
在患有慢性阻塞性肺病 (COPD) 的医疗保险受益人中,肺康复 (PR) 的使用率仍然很低,在2013年至2019年期间仅略有增加,从2.5%增加到4.0%. 年龄较小和专业护理等因素与PR使用率较高有关.
科学领域:
- 肺部病理学 肺部病理学
- 获得医疗保健 获得医疗保健 获得医疗保健
- 公共卫生 公共卫生
背景情况:
- 肺部康复 (PR) 显著改善慢性阻塞性肺病 (COPD) 患者的结果,包括运动耐受性,功能能力,呼吸障碍和生活质量.
- 尽管其已被证明有好处,但COPD患者对公关服务的访问和使用仍然不够理想.
- 了解影响公关使用的趋势和因素对于改善患者护理和结果至关重要.
研究的目的:
- 检查诊断为慢性阻塞性肺病 (COPD) 的成年人使用肺康复 (PR) 的趋势.
- 确定与大量COPD患者中使用PR相关的人口,临床和社会经济因素.
- 评估医疗保险受益人群中在一定的时间内PR利用率的变化.
主要方法:
- 从2013年到2019年,对20%的医疗保险受益人群进行了回顾性分析.
- 根据门诊访问或住院住院的诊断代码识别COPD的成年人.
- 使用现行程序术语和医疗保健共同程序编码系统代码来确定PR利用率;用于识别相关因素的后勤回归模型.
主要成果:
- 观察到PR利用率略有增加,从2013年的2.5%上升到2019年的4.0%,表明总体使用率持续低.
- 与较高的PR使用相关的因素包括年龄较小 (66-74岁),白人,社会经济地位较高,并发症得分较低,城市居住和肺病学家的护理.
- 大多数患有COPD的医疗保险受益者在研究期间没有参加PR计划.
结论:
- 在患有COPD的医疗保险受益者中,利用肺康复 (PR) 的比例变化很小,并且仍然很低.
- 可能需要有针对性的干预措施来改善这种患者群体的PR访问和吸收.
- 进一步的研究应该探索PR访问的障碍和增加其利用的策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Pulmonary Function Tests
334
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
334
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
208
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
208
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


